Find in Library

The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival

oleh: Alexey V. Danilov, Ian W. Flinn, Matthew S. Davids, Beth Gregory, Ohad Bentur, David Sidransky, Jennifer R. Brown